Diagnosis and treatment of TRK fusion-positive GI cancers

Episode 1 September 23, 2021 00:18:01
Diagnosis and treatment of TRK fusion-positive GI cancers
COR2ED Medical Education
Diagnosis and treatment of TRK fusion-positive GI cancers

Sep 23 2021 | 00:18:01

/

Show Notes

In this podcast, NTRK CONNECT members Prof Frédérique Penault-Llorca (University of Clermont-Ferrand, France) and Prof Andrea Sartore-Bianchi (Niguarda Cancer Centre, Milan, Italy) provide both a pathologist and medical oncologist perspective about the detection and treatment of TRK fusion-positive GI cancers, with a particular focus on colorectal cancer.

Penault-Llorca and Sartore-Bianchi start by explaining TRK fusion biology, the role as oncogenic drivers and briefly describe the two approved TRK inhibitors. They then discuss the challenges of finding patients harboring these fusions, referring to how enrichment strategies and predictors can aid identification in patients with GI cancers. Finally, they discuss key efficacy and safety data for larotrectinib and entrectinib, as well as mentioning second-generation products in development to tackle mechanisms of resistance.

Other Episodes

Episode 2

July 11, 2022 00:23:31
Episode Cover

Shared decision-making in nmCRPC

Shared decision-making in nmCRPC: Treatment considerations to maintain quality of life COR2ED Medical Education: Brenda Martone, a nurse practitioner at Northwestern Medicine in Chicago...

Listen

Episode 16

July 13, 2023 00:16:16
Episode Cover

Metastatic gastric and GEJ cancers: clinical case discussions ep.2

COR2ED Medical Education: This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth...

Listen

Episode 1

June 08, 2022 00:22:00
Episode Cover

Management of Skin Toxicity with Multikinase Inhibitors

COR2ED Medical Education: In this podcast, Beth Wittmer RN, Director of Care Management at Florida Cancer Specialists, USA and Prof. Hans Prenen, GI Medical...

Listen